Birdwatch Note
2024-08-17 15:11:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m https://sante.gouv.fr/soins-et-maladies/maladies/infections-sexuellement-transmissibles/cas-groupes-d-infection-par-le-virus-monkeypox
Written by F4486396F350B0A0168AE6364E0DECFB64251E0C0FDC5B8C0C2380A3AE867930
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824785643764883475
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824826415587463335
- noteId - 1824826415587463335
- participantId -
- noteAuthorParticipantId - F4486396F350B0A0168AE6364E0DECFB64251E0C0FDC5B8C0C2380A3AE867930 Participant Details
- createdAtMillis - 1723907495770
- tweetId - 1824785643764883475
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m https://sante.gouv.fr/soins-et-maladies/maladies/infections-sexuellement-transmissibles/cas-groupes-d-infection-par-le-virus-monkeypox
Note Ratings
| rated at | rated by | |
| 2024-08-20 18:00:04 -0500 | Rating Details | |
| 2024-08-20 17:29:00 -0500 | Rating Details | |
| 2024-08-19 16:28:53 -0500 | Rating Details | |
| 2024-08-18 11:21:37 -0500 | Rating Details | |
| 2024-08-18 06:21:03 -0500 | Rating Details | |
| 2024-08-18 05:30:42 -0500 | Rating Details | |
| 2024-08-18 04:04:35 -0500 | Rating Details | |
| 2024-08-18 03:27:01 -0500 | Rating Details | |
| 2024-08-18 03:12:30 -0500 | Rating Details | |
| 2024-08-18 02:40:46 -0500 | Rating Details | |
| 2024-08-18 02:20:57 -0500 | Rating Details | |
| 2024-08-18 01:31:32 -0500 | Rating Details | |
| 2024-08-18 00:27:36 -0500 | Rating Details | |
| 2024-08-17 18:20:27 -0500 | Rating Details | |
| 2024-08-17 17:20:57 -0500 | Rating Details | |
| 2024-08-17 16:34:08 -0500 | Rating Details | |
| 2024-08-17 16:32:33 -0500 | Rating Details | |
| 2024-08-17 15:54:31 -0500 | Rating Details | |
| 2024-08-17 15:45:42 -0500 | Rating Details | |
| 2024-08-17 15:14:14 -0500 | Rating Details | |
| 2024-08-17 14:45:36 -0500 | Rating Details | |
| 2024-08-17 14:17:01 -0500 | Rating Details | |
| 2024-08-17 14:07:59 -0500 | Rating Details | |
| 2024-08-17 14:06:08 -0500 | Rating Details | |
| 2024-08-17 13:36:42 -0500 | Rating Details | |
| 2024-08-17 13:34:35 -0500 | Rating Details | |
| 2024-08-17 13:18:30 -0500 | Rating Details | |
| 2024-08-17 12:57:50 -0500 | Rating Details | |
| 2024-08-17 12:50:33 -0500 | Rating Details | |
| 2024-08-17 12:43:58 -0500 | Rating Details | |
| 2024-08-17 12:29:27 -0500 | Rating Details | |
| 2024-08-17 12:11:06 -0500 | Rating Details | |
| 2024-08-17 12:10:54 -0500 | Rating Details | |
| 2024-08-17 12:00:31 -0500 | Rating Details | |
| 2024-08-17 11:58:41 -0500 | Rating Details | |
| 2024-08-17 11:52:36 -0500 | Rating Details | |
| 2024-08-17 11:29:31 -0500 | Rating Details | |
| 2024-08-17 11:29:11 -0500 | Rating Details | |
| 2024-08-17 11:25:05 -0500 | Rating Details | |
| 2024-08-17 11:19:16 -0500 | Rating Details | |
| 2024-08-17 11:15:58 -0500 | Rating Details | |
| 2024-08-17 11:15:28 -0500 | Rating Details | |
| 2024-08-17 10:57:03 -0500 | Rating Details | |
| 2024-08-17 10:53:41 -0500 | Rating Details | |
| 2024-08-17 10:45:32 -0500 | Rating Details | |
| 2024-08-17 10:40:12 -0500 | Rating Details | |
| 2024-08-17 10:39:19 -0500 | Rating Details | |
| 2024-08-17 10:38:06 -0500 | Rating Details | |
| 2024-08-17 10:36:10 -0500 | Rating Details | |
| 2024-08-17 10:36:10 -0500 | Rating Details | |
| 2024-08-17 10:33:36 -0500 | Rating Details | |
| 2024-08-17 10:30:28 -0500 | Rating Details | |
| 2024-08-17 10:29:26 -0500 | Rating Details | |
| 2024-08-17 10:29:13 -0500 | Rating Details | |
| 2024-08-17 10:29:12 -0500 | Rating Details | |
| 2024-08-17 10:29:00 -0500 | Rating Details | |
| 2024-08-17 10:28:21 -0500 | Rating Details | |
| 2024-08-17 10:27:58 -0500 | Rating Details | |
| 2024-08-17 10:27:56 -0500 | Rating Details | |
| 2024-08-17 10:25:31 -0500 | Rating Details | |
| 2024-08-17 10:23:57 -0500 | Rating Details | |
| 2024-08-17 10:23:31 -0500 | Rating Details | |
| 2024-08-17 10:23:09 -0500 | Rating Details | |
| 2024-08-17 10:22:35 -0500 | Rating Details | |
| 2024-08-17 10:20:42 -0500 | Rating Details | |
| 2024-08-17 10:19:32 -0500 | Rating Details | |
| 2024-08-17 10:18:10 -0500 | Rating Details | |
| 2024-08-17 10:17:41 -0500 | Rating Details | |
| 2024-08-19 02:15:43 -0500 | Rating Details | |
| 2024-08-18 06:22:40 -0500 | Rating Details | |
| 2024-08-18 01:20:37 -0500 | Rating Details | |
| 2024-08-17 23:55:38 -0500 | Rating Details | |
| 2024-08-17 17:20:06 -0500 | Rating Details | |
| 2024-08-17 16:51:50 -0500 | Rating Details | |
| 2024-08-17 15:32:33 -0500 | Rating Details | |
| 2024-08-17 13:44:33 -0500 | Rating Details | |
| 2024-08-17 13:33:41 -0500 | Rating Details | |
| 2024-08-17 12:26:30 -0500 | Rating Details | |
| 2024-08-17 11:21:26 -0500 | Rating Details | |
| 2024-08-17 11:17:19 -0500 | Rating Details | |
| 2024-08-17 11:03:53 -0500 | Rating Details | |
| 2024-08-17 11:02:07 -0500 | Rating Details | |
| 2024-08-17 10:56:56 -0500 | Rating Details | |
| 2024-08-17 10:40:49 -0500 | Rating Details | |
| 2024-08-17 10:15:56 -0500 | Rating Details | |
| 2024-08-17 10:15:26 -0500 | Rating Details | |
| 2024-08-17 10:12:05 -0500 | Rating Details |